Defending the Latest Class Actions: GLP-1 Injectables for Diabetes and Weight Loss

As GLP-1 injectables gain popularity for diabetes and weight loss, legal challenges are rising. With over 1,000 lawsuits filed, plaintiffs cite severe side effects like gastroparesis and intestinal blockage. This litigation raises critical questions about safety and accountability. Learn how defense attorneys can navigate these challenges and stay informed about the evolving landscape of GLP-1 lawsuits and their implications for pharmaceutical companies and patients.